Literature DB >> 10811588

Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial.

R M Califf1, K S Pieper, K L Lee, F Van De Werf, R J Simes, P W Armstrong, E J Topol.   

Abstract

BACKGROUND: When a patient survives thrombolysis for acute myocardial infarction, little information from large studies exists from which to estimate prognosis during follow-up visits. METHODS AND
RESULTS: Baseline, in-hospital, and later survival data were collected from 41 021 patients enrolled in Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries, a randomized trial of 4 thrombolytic-heparin regimens with standard aspirin and beta-blockade. Cox proportional hazards models were developed to predict 1-year survival in 30-day survivors (n=37 869) from baseline clinical and ECG factors and in-hospital factors; a combined model then was developed (C-index 0.800). The model was simplified into a nomogram to predict individual outcomes (C-index 0.754). Factors reflecting demographics (advanced age, lighter weight), larger infarctions (higher Killip class, lower blood pressure, faster heart rate, longer QRS duration), cardiac risk (smoking, hypertension, prior cerebrovascular disease), and arrhythmia were important predictors of death between 30 days and 1 year. Black race was associated with a substantial increase in risk after considering other factors. Revascularization was associated with reduced risk between 30 days and 1 year.
CONCLUSIONS: When evaluating a patient who has survived acute infarction treated with thrombolysis, clinicians can estimate the likelihood of survival from factors easily measured during admission. Although many risk factors clearly relate to age, left ventricular dysfunction, or clinical instability, black race is an unexplained risk factor requiring further examination.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811588     DOI: 10.1161/01.cir.101.19.2231

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  20 in total

1.  Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: results from the OMEGA study.

Authors:  Spyridon Liosis; Timm Bauer; Rudolf Schiele; Helmut Gohlke; Martin Gottwik; Hugo Katus; Georg Sabin; Ralf Zahn; Steffen Schneider; Bernhard Rauch; Jochen Senges; Uwe Zeymer
Journal:  Clin Res Cardiol       Date:  2013-06-06       Impact factor: 5.460

Review 2.  Explicit risk in acute coronary syndrome management.

Authors:  Merril L Knudtson; Colleen M Norris; P Diane Galbraith; Jaro Hubacek; William A Ghali
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

Review 3.  "Obesity paradox" in coronary artery disease.

Authors:  Ibrahim Akin; Christoph A Nienaber
Journal:  World J Cardiol       Date:  2015-10-26

4.  Cardiovascular disease among women residing in rural America: epidemiology, explanations, and challenges.

Authors:  Herman A Taylor; Gail D Hughes; Robert J Garrison
Journal:  Am J Public Health       Date:  2002-04       Impact factor: 9.308

5.  Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.

Authors:  Renato D Lopes; Laine E Elliott; Harvey D White; Judith S Hochman; Frans Van de Werf; Diego Ardissino; Torsten T Nielsen; W Douglas Weaver; Petr Widimsky; Paul W Armstrong; Christopher B Granger
Journal:  Eur Heart J       Date:  2009-06-06       Impact factor: 29.983

Review 6.  Risk Stratification in Patients with Coronary Artery Disease: A Practical Walkthrough in the Landscape of Prognostic Risk Models.

Authors:  Sergio Buccheri; Paolo D'Arrigo; Gabriele Franchina; Davide Capodanno
Journal:  Interv Cardiol       Date:  2018-09

7.  Severity of coronary artery disease in obese patients undergoing coronary angiography: "obesity paradox" revisited.

Authors:  Ashutosh Niraj; Jyotiranjan Pradhan; Jyotiranjan Pradahan; Hesham Fakhry; Vikas Veeranna; Luis Afonso
Journal:  Clin Cardiol       Date:  2007-08       Impact factor: 2.882

Review 8.  Risk stratification for ST segment elevation myocardial infarction in the era of primary percutaneous coronary intervention.

Authors:  Richard A Brogan; Christopher J Malkin; Phillip D Batin; Alexander D Simms; James M McLenachan; Christopher P Gale
Journal:  World J Cardiol       Date:  2014-08-26

9.  Multiple cardiovascular comorbidities and acute myocardial infarction: temporal trends (1990-2007) and impact on death rates at 30 days and 1 year.

Authors:  David D McManus; Hoa L Nguyen; Jane S Saczynski; Mayra Tisminetzky; Peter Bourell; Robert J Goldberg
Journal:  Clin Epidemiol       Date:  2012-05-07       Impact factor: 4.790

10.  Dynamic TIMI risk score for STEMI.

Authors:  Sameer T Amin; David A Morrow; Eugene Braunwald; Sarah Sloan; Charles Contant; Sabina Murphy; Elliott M Antman
Journal:  J Am Heart Assoc       Date:  2013-01-29       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.